Target intelligence / Profile preview

Lens surface protein deposit

Molecular classification
Other (mixture of proteins, lipids, mucins, not a defined molecular entity or family)
01

Overview

Lens surface protein deposits are accumulations of tear film components—primarily proteins like lysozyme, lipocalin, lactoferrin, albumin, and IgA—alongside mucins, lipids, calcium, and environmental contaminants on the anterior (and occasionally posterior) surfaces or within the matrix of contact lenses. These deposits form rapidly upon lens insertion and are encouraged by factors such as lens material, surface charge, and hydrophilicity. The deposits can denature, losing normal protein structure and function, leading to impaired lens clarity, reduced antimicrobial protection, ocular irritation, and inflammation. Clinical symptoms include discomfort, dryness, blurred vision, and a higher risk of ocular complications. Removal methods involve chemical cleaning solutions, enzymatic digestion, physical rubbing, and, most recently, electrophoresis. Unlike true molecular targets, lens surface protein deposits represent a pathology associated with medical devices rather than a specific molecular entity.

Other names
Lens debrisContact lens protein depositProtein filmJelly bumpsLens calculi
02

Mechanism of action

Physical/chemical removal—detergent, enzymatic digestion (e.g., proteases), chelating agents, electrophoresis[3][5][6]

03

Biological functions

Other (not a single biomolecule—proteins in deposits such as lysozyme are involved in antibacterial defense and tear film homeostasis, but the deposit itself is pathogenic[2][3][4])
04

Disease associations

Other (associated with ocular irritation, contact lens intolerance, giant papillary conjunctivitis, superior limbic keratoconjunctivitis[3], not directly with molecularly defined diseases)
05

Safety considerations

Ocular inflammation (giant papillary conjunctivitis, superior limbic keratoconjunctivitis)[3]Reduced lens comfort and vision[1][3]Increased risk of infection due to reduced lysozyme antimicrobial activity[2][3][6]Possible autoimmune response to denatured protein[2][3]
06

Interacting drugs

Multipurpose contact lens care solutions

2 more in the full profile.

Beyond the preview

Go deeper on Lens surface protein deposit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lens surface protein deposit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call